Dedicated EC Products
Women’s access to EC is significantly influenced by the availability of EC products in their setting. While off-label use of conventional oral contraceptives for EC (i.e the Yuzpe regimen) represents an important option to women who otherwise would not have access to EC, a dedicated EC product – one that is packaged and labeled specifically for EC use – should be widely available through a range of outlets (clinics, pharmacies, hospitals, etc).
ICEC has worked with pharmaceutical companies and other partners to help increase access to EC. (Early steps towards developing and registering a dedicated EC product are described in our History.) Gedeon Richter was the first company to manufacture a dedicated EC product, followed by HRA Pharma; now many manufacturers are providing EC to markets around the world. More than 140 countries have registered at least one dedicated EC product through their drug regulatory processes. Registered EC products are listed in our country directory.
However, other barriers may still need to be addressed. Accessibility to EC varies across the private, public, and NGO sectors. Donor procurement of EC also varies considerably. Finally, many countries have yet to register the range of EC products available and a few still do not have any dedicated EC products. This map shows where EC is registered and whether it is available over the counter.